ePRO Monitoring for Chronic Disease Care Transitions
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial tests a digital health app (ePRO Application) designed to help manage symptoms after hospital discharge for individuals with multiple chronic conditions. The app aims to detect early warning signs of health issues and alert medical teams to prevent complications. Participants will receive either standard care or use the app to determine if it reduces post-discharge problems. Individuals who have stayed in the hospital for over a day and have conditions like asthma, diabetes, or heart disease might be suitable candidates. As an unphased trial, this study offers a unique opportunity for patients to contribute to innovative healthcare solutions and potentially improve their own post-discharge outcomes.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.
What prior data suggests that this ePRO Application is safe for use in chronic disease care transitions?
Research has shown that using the ePRO App for real-time symptom tracking appears promising. Studies have found that electronic patient-reported outcomes (ePROs) can help reduce issues during changes in care. When patients use the app to report symptoms, doctors can quickly identify and address any problems.
The system's safety seems reliable. Patients have used similar tools without major issues. Although specific safety data for the ePRO App itself is not available, electronic monitoring in healthcare has generally been well-received.
For those considering joining a trial that uses ePRO, the app is designed to catch problems early and improve patient care. Safety reports so far suggest it is a low-risk addition to healthcare routines.12345Why are researchers excited about this trial?
Researchers are excited about this trial because it explores the use of an ePRO (electronic Patient-Reported Outcomes) application to enhance chronic disease care transitions. Unlike traditional care, which often relies on periodic in-person visits, this approach leverages digital technology to continuously collect patient data in real-time. This method could lead to more personalized and timely interventions, potentially improving patient outcomes and reducing adverse events after discharge. By integrating patient-reported information seamlessly into the care process, this trial aims to innovate how healthcare providers monitor and respond to chronic disease management.
What evidence suggests that the ePRO Application is effective for minimizing post-discharge adverse events in patients with multiple chronic conditions?
Research has shown that the ePRO (electronic Patient-Reported Outcome) app, which participants in this trial may use, improves patient care by tracking symptoms in real-time. Studies have found that ePRO tools enable patients to report symptoms quickly and accurately. This leads to faster responses from healthcare providers, potentially reducing complications after hospital discharge. ePRO systems are particularly useful for managing long-term conditions by providing timely and detailed patient feedback. This feedback aids doctors in making better decisions and adjusting treatments as needed. Overall, early findings suggest that ePRO enhances patient monitoring and safety during changes in care.16789
Who Is on the Research Team?
Anuj K Dalal, MD
Principal Investigator
Brigham and Women's Hospital
Are You a Good Fit for This Trial?
This trial is for adults with two or more chronic conditions like heart disease, diabetes, COPD, etc., who are hospitalized and will be discharged to home or a facility. They must speak English or have an English-speaking healthcare proxy.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Baseline Pre-implementation
Development and validation of a predictive model of post-discharge AEs for MCC patients using PRO questionnaires and EHR-derived variables
Main Trial (RCT) Period
Randomized controlled trial comparing real-time symptom monitoring intervention to usual care for patients with MCCs transitioning out of the hospital
Follow-up
Participants are monitored for safety and effectiveness after discharge, focusing on adverse events and healthcare utilization
What Are the Treatments Tested in This Trial?
Interventions
- ePRO Application
Find a Clinic Near You
Who Is Running the Clinical Trial?
Brigham and Women's Hospital
Lead Sponsor
RAND
Collaborator